When used alongside standard-of-care in a multicenter premarket clinical study, the Tango Belt demonstrated paradigm-shifting outcomes, achieving a 91% reduction in fall-induced hip fractures in at-risk older adults as compared to the standard of care alone.

“Today marks a crucial step forward in addressing fall-induced hip fractures.” Wamis Singhatat, CEO, ActiveProtectivePost this

“Today marks a crucial step forward in addressing fall-induced hip fractures, a devastating injury that impacts countless lives of older adults every year,” stated ActiveProtective’s CEO, Wamis Singhatat. “With the FDA’s marketing authorization and Breakthrough Device Designation of the Tango Belt, we are proud to introduce an innovation that sets a new standard for safer mobility and fall injury mitigation for at-risk older adults. This is the culmination of over a decade of unwavering dedication by our team of developers and clinicians. We are grateful to our partners and investors for making this vision a reality.”